Skip to content

Baby Soap study in healthy babies

Safety In-Use Study to Assess the Cutaneous Tolerance of Baby Soap in Healthy Babies of 0 to 36 Months of Age

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027380
Enrollment
36
Registered
2020-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Baby soap: Wet baby�s face and body
apply the Baby Soap generously, gently working up a lather and rinse well. Use once daily for 14 days. Control Intervention1: Not Applicable: Not Applicable

Sponsors

Azafran Innovacion Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Babies in the age group of 0 (including new born full term babies of Day 1) to 36 months (inclusive of both genders) at the time of consent. 2) APGAR score >7 at 1 and 5 minutes with no resuscitation required at birth for babies of 0-7 days. 3) Babies general in good health as determined from a recent medical history 4) Babies mother/legal representative, preferably mother willing to give a voluntary written parental informed consent and agree to come for regular follow up. 5) Babies mother/legal representative, preferably mother willing to abide by and comply with the study protocol. 6) Babies should not participate in any other clinical study during participation in the current study.

Exclusion criteria

Exclusion criteria: 1) Babiesââ?¬• mother/ legal caretaker not willing to stop the use of other baby body milk /lotion / massage oil or any other baby face/body moisturizing product during the study period. 2) Chronic illness which may influence the cutaneous state as per Investigator. 3) Babies on any systemic medication. 4) Babies participating in a similar clinical study, currently or during the previous 30 days. 5) Any baby, in the Investigators opinion not considered suitable for enrollment. 6) A known history or present condition of allergic response to any other concern that may require medical attention. 7) Babies with medical history (past | present) of significant dermatological diseases or conditions, such as atopy, psoriasis, vitiligo or other conditions known to alter skin appearance or physiologic response (e.g. porphyria) chronic urticaria, or sunburn, rashes.

Design outcomes

Primary

MeasureTime frame
1. The safety of the test product will be evaluated the on skin in terms of mildness, gentleness and non-irritability of babies� skin by pediatrician assessment change from baseline. 2. To determine the baby experienced no tear, provide quick clean, smooth and gentle effect on baby skin and hair by subjective assessment questionnaire from babies� mother/ legal caretaker after test product application on Day 15.Timepoint: 1. Day 01 before application to Day 15 after application. 2. Day 15 after test product application.

Secondary

MeasureTime frame
1. The effect of test product will be evaluated on improvement in the skin hydration using Corneometer�® CM 825 or MoistureMeter SC change from baseline.Timepoint: 1. Day 01 before application to Day 15 after application.

Countries

India

Contacts

Public ContactMs Maheshvari Patel

Cliantha Research

nkpatel@cliantha.com9909013286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026